Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

FDA continues review of drospirenone-containing OCs

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      FDA.FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone. Internet Document: [2 pages], 26 Sep 2011. Available from: URL: http://www.fda.gov

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    FDA continues review of drospirenone-containing OCs. React. Wkly. 1371, 2 (2011). https://doi.org/10.2165/00128415-201113710-00002

    Download citation

    Keywords

    • Estrogen
    • Risk Management
    • Oral Contraceptive
    • Reproductive Health
    • Advisory Committee